RNWL
INTERNATIONAL REGISTRATION RENEWED
09/04/2026
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
Starpharma Pty Limited
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticals, pharmaceutical preparations, and pharmaceutical drugs for medical purposes for prevention of viral and bacterial disease, namely, bacterial vaginosis, herpes simplex virus, human papilloma virus, and human immunodeficiency virus (HIV); chemical preparations for pharmaceutical and medical purposes for the prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus and human immunodeficiency virus (HIV); chemical compounds in the nature of antimicrobial or ph balancing or microbial balancing substances all for medical purposes, namely, for treating and preventing vaginal microbial imbalance, vaginal pH imbalance, vaginal odor and discharge, bacterial vaginosis, viral STD, vaginaitis, vaginal thrush, vaginal disease symptom relief including itching, odor, and discharge, for maintaining a healthy balance of vaginal flora and for the reestablishment of the bacterial vaginal flora; polyvalent compounds and dendrimers sold as integral component parts of pharmaceuticals preparations all for medical purposes for the treatment and prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus, human immunodeficiency virus (HIV); antimicrobial preparations, namely, microbicidal preparations in the nature of gels, films, solutions, lubricants for vaginal and rectal use for prevention of bacterial vaginosis, herpes simplex virus, human papilloma virus, human immunodeficiency virus (HIV); chemical contraceptives, namely, sponges, gels, foams, creams, films, solutions, suspensions and lotions for use in preventing HIV and other sexually transmitted infections; prophylactic preparations for prevention of pregnancy and microbial disease of the reproductive system, namely, chemical contraceptives and antibacterial preparations in the nature of sponges, suppositories, sexual lubricants, gels, foams, creams, films, solutions, suspensions and lotions; pharmaceutical preparations in the nature of vaginal gels and lubricants all for the prevention of pregnancy and sexually transmitted infections and diseases of the human reproductive system
Classe 10
Contraceptive apparatus, namely, intravaginal cervical barriers; prophylactic instruments for use to prevent pregnancy and disease, namely, condoms, diaphragms, and intrauterine devices
Histórico de despachos e eventos da marca no USPTO.
58 publicações encontradas
INTERNATIONAL REGISTRATION RENEWED
09/04/2026
19/03/2026
GENERIC MADRID TRANSACTION SENT TO IB
04/02/2026
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
04/02/2026
GENERIC MADRID TRANSACTION CREATED
04/02/2026
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
13/08/2025
CANCELLED SECTION 71
13/12/2024
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
29/05/2023
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/06/2019
NEW REPRESENTATIVE AT IB RECEIVED
26/04/2019
CORRECTION UNDER SECTION 7 - PROCESSED
08/12/2018
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
04/12/2018
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
28/11/2018
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/10/2018
TEAS SECTION 7 REQUEST RECEIVED
30/10/2018
FINAL DECISION TRANSACTION PROCESSED BY IB
06/10/2018
FINAL DISPOSITION NOTICE SENT TO IB
13/09/2018
FINAL DISPOSITION PROCESSED
13/09/2018
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
29/08/2018
REGISTERED-PRINCIPAL REGISTER
29/05/2018
NOTIFICATION PROCESSED BY IB
16/03/2018
PUBLISHED FOR OPPOSITION
13/03/2018
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
21/02/2018
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
21/02/2018
NOTICE OF PUBLICATION
21/02/2018
EXPARTE APPEAL TERMINATED
06/02/2018
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2018
EXAMINERS AMENDMENT MAILED
06/02/2018
EXAMINER'S AMENDMENT ENTERED
06/02/2018
EXAMINERS AMENDMENT -WRITTEN
06/02/2018
TEAS/EMAIL CORRESPONDENCE ENTERED
23/01/2018
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/01/2018
EX PARTE APPEAL-INSTITUTED
22/01/2018
JURISDICTION RESTORED TO EXAMINING ATTORNEY
22/01/2018
EXPARTE APPEAL RECEIVED AT TTAB
22/01/2018
TEAS REQUEST FOR RECONSIDERATION RECEIVED
21/01/2018
NEW REPRESENTATIVE AT IB RECEIVED
27/07/2017
FINAL REFUSAL MAILED
21/07/2017
FINAL REFUSAL WRITTEN
20/07/2017
PARTIAL INVALIDATION PROCESSED BY THE IB
07/07/2017
TEAS/EMAIL CORRESPONDENCE ENTERED
27/06/2017
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/06/2017
ASSIGNED TO LIE
23/06/2017
REFUSAL PROCESSED BY IB
09/06/2017
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/05/2017
NEW REPRESENTATIVE AT IB RECEIVED
18/05/2017
CORRECTION TRANSACTION RECEIVED FROM IB
28/04/2017
NEW REPRESENTATIVE AT IB RECEIVED
10/02/2017
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/02/2017
REFUSAL PROCESSED BY MPU
09/02/2017
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/02/2017
NON-FINAL ACTION WRITTEN
08/02/2017
ASSIGNED TO EXAMINER
06/02/2017
APPLICATION FILING RECEIPT MAILED
20/12/2016
NEW REPRESENTATIVE AT IB RECEIVED
16/12/2016
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/12/2016
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/12/2016
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
01/12/2016
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.